Developer of therapies for treating disc herniations in the spine for discectomy patients. The company offers an annular prosthesis device that enables the direct reconstruction of weakened and ruptured annulus and soft tissues of the spine following discectomy surgery.

Developer of minimally invasive and clinically effective devices designed to address unmet needs in the field of urology. The company’s initial focus is on improving the standard of care for patients with Benign Prostatic Hyperplasia using the UroLift System, a minimally invasive permanent implant system.

The company’s online digital services enable customers to share memories and celebrate great moments by transforming digital photography online or via mobile phones into personalized products and gifts such as photo books, personalized calendars, personalized phone cases and other related items.

Owner and operator of e-commerce websites and online communities. The company offers private and professional users a marketplace to trade various products, including books, videos, CDs, DVDs and games, electronics, clothes, childcare products, apparel, home and garden products, automobiles and many other products.

Royalty Pharma owns a diversified portfolio of biotechnology product royalties and intellectual properties. Royalty Pharma has grown through the acquisition of revenue producing intellectual property – principally, royalty interests in marketed and late stage development biopharmaceutical products.